000025703 000__ 05396cam\a2200649\i\4500 000025703 001__ 25703 000025703 003__ SzGeWIPO 000025703 005__ 20230203230017.0 000025703 008__ 090902s2009\\\\mau\\\\\rb\\\\001\0\eng\\ 000025703 010__ $$a2009936223 000025703 020__ $$a9781848447882$$qPrint 000025703 020__ $$z9781849801935$$qeBook 000025703 035__ $$a(DLC)15890271 000025703 035__ $$a(DLC)2009936223 000025703 035__ $$a(wipo)15890271 000025703 035__ $$a(OCoLC)319211196 000025703 040__ $$aDLC$$beng$$erda$$cDLC$$dCaBNVSL 000025703 041__ $$aeng 000025703 043__ $$ae------ 000025703 050_4 $$aK1519.B54$$bR65 2009 000025703 08204 $$a660.6$$222 000025703 08204 $$a346.048$$221 000025703 084__ $$aF 630 CAS.R 000025703 090__ $$c28069$$d28059 000025703 1001_ $$aCastle, David.$$eEditor. 000025703 24514 $$aThe Role of Intellectual Property Rights in Biotechnology Innovation 000025703 264_1 $$aCheltenham :$$bEdward Elgar,$$c2009. 000025703 300__ $$a480 pages ;$$c23 cm 000025703 336__ $$atext$$btxt$$2rdacontent 000025703 337__ $$aunmediated$$bn$$2rdamedia 000025703 338__ $$avolume$$bnc$$2rdacarrier 000025703 504__ $$aIncludes bibliographical references and index. 000025703 5050_ $$aIntroduction -- Part I: Intellectual Property Rights in Innovation Systems – Introduction; 1. Are Intellectual Property Rights Quanta of Innovation?; 2. Intellectual Property Rights and Innovation Systems: Issues for Governance in a Global Context; 3. Intellectual Property Rights Policy for Gene-Related Inventions – Toward Optimum Balance Between Public and Private Ownership -- Part II: Intellectual Property Management In Biotechnology – Introduction; 4. Fundamentals of Intellectual Property Management; 5. Making a Return on R&D: A Business Perspective; 6. Looking Beyond the Firm: Intellectual Asset Management and Biotechnology -- Part III: Intellectual Property Rights in Relation to Other Measures of Innovation – Introduction; 7. Increasing Internal Value from Patents: The Role of Organizational Arrangements; 8. Language System (LS) 3.0: An Agenda for a Model of Innovation Valuation; 9. Measurement of Innovation and Intellectual Property Management: Challenging Processes -- Part IV: Beyond Patent Length – Introduction; 10. Open Development: Is the ‘Open Source’ Analogy Relevant to Biotechnology?; 11. On the Border: Biotechnology, the Scope of Intellectual Property and the Dissemination of Scientific Benefits; 12. On the Comparative Institutional Economics of Intellectual Property in Biotechnology -- Part V: Innovation Governance – Introduction; 13. Accessibility of Biological Data: A Role for the European Database Right?; 14. Biotechnology Patents, Public Trust and Patent Pools: The Need for Governance?; 15. Agricultural Biotechnology and Trends in the Intellectual Property Rights Regime: Emerging Challenges for Developing Countries -- Part VI: National, International and Historical Comparisons – Introduction; 16. The Role of Intellectual Property Rights in Biotechnology Innovation: National and International Comparisons; 17. Intellectual Property, Information and Divergences in Economic Development – Institutional Patterns and Outcomes circa 1421–2000; 18. Watch What You Export: The History of Medical Exceptions from Patentability -- Index 000025703 520__ $$aIntellectual property rights (IPRs), particularly patents, occupy a prominent position in innovation systems, but to what extent they support or hinder innovation is widely disputed. Through the lens of biotechnology, this book delves deeply into the main issues at the crossroads of innovation and IPRs to evaluate claims of the positive and negative impacts of IPRs on innovation. An international group of scholars from a range of disciplines – economic geography, health law, business, philosophy, history, public health, management – examine how IPRs actually operate in innovation systems, not just from the perspective of theory but grounded in their global, regional, national, current and historical contexts. In so doing, the contributors seek to uncover and move beyond deeply held assumptions about the role of IPRs in innovation systems. Scholars and students interested in innovation, science and technology policy, intellectual property rights and technology transfer will find this volume of great interest. The findings will also be of value to decision makers in science and technology policy and managers of intellectual property in biotechnology and venture capital firms. 000025703 650_0 $$aBiotechnology. 000025703 650_0 $$aBiotechnology$$vCongresses. 000025703 650_0 $$aIntellectual property. 000025703 650_0 $$aPatents$$zEurope. 000025703 650_0 $$aIntellectual property$$zEurope. 000025703 650_4 $$aIntellectual property 000025703 650_6 $$aPropriété intellectuelle$$vGuides, manuels, etc. 000025703 650_6 $$aBiotechnologie$$vGuides, manuels, etc. 000025703 651_0 $$aEurope$$xCommerce$$xLaw and legislation. 000025703 651_0 $$aItaly$$xCommerce$$xLaw and legislation. 000025703 7001_ $$aB. Asheim,$$aC. Ayerbe,$$aR.Y. Boadi,$$aJ.A. Bovenberg,$$aT. Bubela,$$aD. Castle,$$aT. Caulfield,$$aS. Chaturvedi,$$aL.M. Cloutier,$$aL.M. Cloutier,$$aA.S. Daar,$$aK.L. Durell,$$aC.W. Francis,$$aA.J. Glass,$$aE.R. Gold,$$aJ.A. Holbrook,$$aM. Ingham,$$aI. Inkster,$$aA.G. Isaac,$$aF.S. Kieff,$$aC. May,$$aE. Métais,$$aL. Mitkova,$$aF.X. Nunez,$$aS. Oriel,$$aW.G. Park,$$aT. Piper,$$aS. Sirois,$$aP.H. Sullivan,$$aK. Sumikura,$$aF. Valentin,$$aC. Zeller.$$eContributors. 000025703 85641 $$uhttps://www.elgaronline.com/display/edcoll/9781847209801/9781847209801.xml$$yView eBook 000025703 906__ $$a0$$bibc$$corignew$$d2$$eepcn$$f20$$gy-gencatlg 000025703 942__ $$cMON$$jF 630 CAS.R 000025703 952__ $$w2010-03-12$$p2010-0261$$r99.00$$u39756$$bMAIN$$10$$kF 630 CAS.R$$v2010-03-12$$zTagged$$71 000025703 952__ $$w2010-05-11$$p2010-0402$$r99.00$$u39897$$bMAIN$$10$$kF 630 CAS.R$$v2010-05-11$$zTagged$$71 000025703 955__ $$apc14 2009-09-02$$axh00 2010-03-09 to USPL/STM 000025703 980__ $$aBIB$$aOS 000025703 999__ $$c28069$$d28069